Denosumab versus zoledronic acid for primary osteoporosis: a 36-month retrospective cohort study on bone mineral density changes

Xin Zou, Xiaomeng Huang, Mingxin Tang, Yuyan Zhu, Cheng Li, Liangjun Zhao

Open source

DOI
10.3389/fmed.2026.1842793
Published
2026-07-29
Container
Frontiers in Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1842793,
  title = {Denosumab versus zoledronic acid for primary osteoporosis: a 36-month retrospective cohort study on bone mineral density changes},
  author = {Xin Zou and Xiaomeng Huang and Mingxin Tang and Yuyan Zhu and Cheng Li and Liangjun Zhao},
  year = {2026},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2026.1842793},
  url = {https://doi.org/10.3389/fmed.2026.1842793}
}

RIS

TY  - JOUR
TI  - Denosumab versus zoledronic acid for primary osteoporosis: a 36-month retrospective cohort study on bone mineral density changes
AU  - Xin Zou
AU  - Xiaomeng Huang
AU  - Mingxin Tang
AU  - Yuyan Zhu
AU  - Cheng Li
AU  - Liangjun Zhao
PY  - 2026
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2026.1842793
UR  - https://doi.org/10.3389/fmed.2026.1842793
ER  - 

APA

Zou, X., Huang, X., Tang, M., Zhu, Y., Li, C., & Zhao, L. (2026). Denosumab versus zoledronic acid for primary osteoporosis: a 36-month retrospective cohort study on bone mineral density changes. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1842793

Source records